Acute Treatment of Bipolar II Depression
Trial ID or NCT#
NCT00074776
Status
NOT RECRUITING
Purpose
This study will compare the medications lithium and lamotrigine (Lamictal®) in treating depression in individuals with bipolar II disorder.
Official Title
Acute Treatment of Bipolar II Depression
Eligibility Criteria
Ages Eligible for Study: 18 Years to 55 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Current diagnosis of bipolar II disorder
Exclusion Criteria:
- - Use of lithium or lamotrigine - Intolerance to lithium or lamotrigine - Substance abuse or dependence within the last month - Suicidal thoughts - Unstable medical conditions - Pregnancy or breast-feeding - Stable on current medications - Use of fluoxetine (Prozac) within 2 weeks of study - Require an antipsychotic medication - Do not speak or read English
Investigator(s)
Trisha Suppes, MD, PhD
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
View on ClinicalTrials.gov
